Here's How to Make Sense of the Canopy Growth, Acreage Deal

The amended deal between the two cannabis companies is a doozy.

Just How Strong Are Constellation Brands' Charts?

I continue to recommend a reduced long exposure on STZ.

Investing in Cannabis? Don't 'Write Off' This Item

Publicly traded cannabis companies are expected to take big write downs on assets, and here's why it matters.

Constellation Brands Could Disappoint the Thirsty Bulls

Let's review the charts and indicators ahead of earnings.

Is Psilocybin the New CBD?

As psychedelic medicines begin to become decriminalized, psilocybin seems to be leading the way in this category.

Compass Pathways Takes Investors on a Trip to Higher Prices

Fresh off IPO, company sees mushrooming opportunity in psilocybin.

The Promise of Hemp Begins to Fade

There are huge problems now plaguing the industry, which was just beginning to recover from last year's oversupply issues.

Shark Bites: Trulieve Cannabis Is High on My List Into the Third Quarter

TCNNF is a 'seed-to-sale' company that offers 155 products.

Capital Raising in Cannabis Falls 67%

Only five companies went public during the first half of 2020 versus 13 in the first half of 2019.

Vape Recovery Goes Up in Smoke Amid Pandemic

Following widely reported lung injuries and bans, the products struggle to come back as concerns over Covid-19 burn on.